Successful Management of Myval Transcatheter Heart Valve Embolization Into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement

• Published in: Texas Heart Institute journal Vol. 51; no. 2; pp. 1 - 5
• Main Authors: García-Escobar, Artemio, Galeote, Guillermo, Jurado-Román, Alfonso, Jiménez-Valero, Santiago, Cabrera, José Ángel, Moreno, Raúl
• Format: Journal Article
• Language: English
• Published: Texas Heart® Institute, Houston 05-11-2024; The Texas Heart Institute
• Subjects: aortic aneurysm, abdominal; Case Reports; heart valve prosthesis; transcatheter aortic valve replacement
• ISSN: 0730-2347; 1526-6702; 1526-6702
• DOI: 10.14503/THIJ-22-7997

Transcatheter heart valve embolization is a serious and rare complication of transcatheter aortic valve replacement. Having a strategy for promptly managing transcatheter heart valve embolization is crucial to avoid emergency conversion from transcatheter aortic valve replacement to open-heart surgery. Many cases of transcatheter heart valve embolization occurring with balloon-expandable prostheses such as the SAPIEN 3 (Edwards LifeSciences Corporation) valve and self-expandable prostheses such as the ACURATE neo (Boston Scientific Corporation) valve have been reported in the literature. Here, for the first time (to the authors’ knowledge), the case of a Myval (Meril Life Sciences Pvt Ltd) transcatheter heart valve embolization during transcatheter aortic valve replacement, which was treated percutaneously with favorable outcomes, is reported.